Italia markets closed

MRTX Mar 2022 190.000 call

OPR - OPR Prezzo differito. Valuta in USD.
Aggiungi a portafoglio
13,090,00 (0,00%)
Alla chiusura: 10:56AM EDT
Schermo intero
Chiusura precedente13,09
Aperto12,58
Denaro2,45
Lettera4,80
Prezzo d'esercizio190,00
Scadenza2022-03-18
Min-Max giorno12,58 - 13,09
Contratto - Min-MaxN/D
Volume20
Open Interest20
  • GlobeNewswire

    (MRTX) Alert: Did You Lose Money on Your Mirati Therapeutics Investment? Contact Johnson Fistel Regarding Investigation

    SAN DIEGO, Nov. 01, 2021 (GLOBE NEWSWIRE) -- Shareholder Rights Law Firm Johnson Fistel, LLP, is investigating potential claims against Mirati Therapeutics, Inc. (NASDAQ: MRTX) for violations of federal securities laws. On November 1, 2021, Mirati, in an SEC filing, disclosed that certain executives would no longer be serving in their positions. In the filing, the Company stated, “On October 28, 2021, it was determined that Daniel R. Faga would cease serving as the Executive Vice President, Chie